WO2024018286A2 - Compositions of lipophilic anchors and the use thereof - Google Patents
Compositions of lipophilic anchors and the use thereof Download PDFInfo
- Publication number
- WO2024018286A2 WO2024018286A2 PCT/IB2023/000557 IB2023000557W WO2024018286A2 WO 2024018286 A2 WO2024018286 A2 WO 2024018286A2 IB 2023000557 W IB2023000557 W IB 2023000557W WO 2024018286 A2 WO2024018286 A2 WO 2024018286A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipophilic
- anchor
- domain
- molecule
- target molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/5432—Liposomes or microcapsules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
Definitions
- a surface can be functionalized with target molecules by coating.
- coating phospholipids can be placed on the surface of a material for implantation in the body to improve the material’s biocompatibility.
- Another example of a functionalized surface is for generating an ELISA assay, where a certain type of protein molecules is coated on a polystyrene surface, to enable the surface for specifically binding molecules having a binding affinity with the protein.
- This coating approach can be simple and unspecific, such as a coating with hydrophobic domains where the target molecules attach to the hydrophobic surface by hydrophobic interactions. Such interactions are stable in an aqueous environment. However, this coating approach is only applicable with hydrophobic surfaces.
- a target molecule For a hydrophilic surface, a target molecule needs to be coated using other interactions, for example, ionic interactions between counter charges or by chemical conjugations.
- the ionic interactions are often weak in an aqueous environment and is often sensitive to charge change (e.g. due to pH change), and the conjugation can be complicated and may require prior chemical modification of the target molecules or may interfere with the normal function of these molecules. Accordingly, a versatile and effective approach to coat target molecules on a hydrophilic surface by simple hydrophobic interactions is needed.
- An embodiment is directed to a lipophilic anchor that includes a conjugation domain linked via a linker domain to a anchor domain having a plurality of hydrophobic tails.
- This lipophilic anchor allows deposition of at least one lipophilic target molecule with affinity for the anchor domain on a hydrophilic surface conjugated to the conjugation domain.
- the conjugation domain is derived from a molecule having at least one functional group selected from: acrylate; methacrylate; maleimide; vinylsulfone; aldehyde; acrylamide; vinyl; thiol; amine; alkylamine: hydroxy; derivatives thereof, and any combination thereof.
- the hydrophobic tails can be at least one saturated, mono-unsaturated, or polyunsaturated hydrocarbons, where the hydrocarbons can be linear, mono-branched, poly-branched, cyclic, polycyclic, or any combination thereof which can be 6 to 20 carbon atoms, for example, 8 to 14 carbon atoms, that are optionally interrupted with one or two oxygen atoms, sulfur atoms, or a combination thereof.
- the anchor domain is derived from a second molecule having 1 to 6 hydrophobic tails, for example 1 and/or 2 and/or 3 hydrophobic tails and a complementary functionality to the functionality of the first molecule.
- the at least one functional group is an acrylate or a thiol and the complimentary functionality can be a thiol or an acrylate, respectively.
- the linker domain is a structural unit generated upon coupling the first molecule to the second molecule to generate the conjugation domain and anchor domain.
- Another embodiment is directed to lipophilic target molecule coated hydrophilic substrate that has a multiplicity of reaction residues of the functionality of the lipophilic anchor disclosed above and a complimentary functionality to the functionality of the conjugation domain of the lipophobic anchor on at least a hydrophilic surface of the hydrophilic substrate and has a multiplicity of lipophilic target molecules non-covalently bound to the plurality of hydrophobic tails of the anchor domain.
- the hydrophilic surface can be a hydrophilic polymer such as a hydrogel.
- the hydrophilic substrate is a hydrogel, for example a dextran-based hydrogel.
- the multiplicity of lipophilic target molecules are selected from at least one biomolecule, such as phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylglycerols (PG), phosphatidylserines (PS), sterols, saccharolipids, lipopeptides, lipoproteins, crude membrane components extracted from mammalian cells.
- the lipophilic target molecule can be a lipid bilayer and the lipophilic target molecule coated hydrophilic substrate in the form of a cell mimic.
- Another embodiment is directed to a method of preparing the lipophilic anchor where a first molecule comprising a multiplicity of functional groups selected from: acrylate; methacrylate; maleimide; vinylsulfone; aldehyde; acrylamide; vinyl; thiol; amine; alkylamine: hydroxy; derivatives thereof, and any combination thereof and a second molecule comprising at least one hydrophobic tail selected from a saturated, mono-unsaturated, and polyunsaturated hydrocarbons and a multiplicity of complimentary functional groups are combined.
- a first molecule comprising a multiplicity of functional groups selected from: acrylate; methacrylate; maleimide; vinylsulfone; aldehyde; acrylamide; vinyl; thiol; amine; alkylamine: hydroxy; derivatives thereof, and any combination thereof and a second molecule comprising at least one hydrophobic tail selected from a saturated, mono-unsaturated, and polyunsaturated hydrocarbons and a multiplicity
- a solvent and/or a catalyst or an initiator can be included such that one can isolate the lipophilic anchor with the conjugation domain from the first molecule, the anchor domain from the second molecule and the linker domain resulting from a reaction between the functional groups and the complimentary functional groups.
- FIG. 1 illustrates the design of lipophilic anchors that include a conjugation domain, a linker domain, and an anchor domain, where the conjugation domain has one or more functional groups to conjugate on the hydrophilic surface and the anchor domain includes two to four aliphatic units that adsorb and stabilize target molecules having lipophilic domains via hydrophobic interactions.
- FIG. 2 shows some reagents useful for synthesis of the lipophilic anchors.
- FIG. 3 illustrates the process of coating a stable lipid layer to a lipophilic anchor modified hydrophilic surface.
- FIG. 4 shows the chemical structure of exemplary lipophilic anchor synthesized using methods according to embodiments.
- FIG. 5 shows structures of a mono lipid and two exemplary lipophilic anchors synthesized using methods, according to embodiments.
- FIG. 6 shows structures and ’H NMR spectra of six exemplary lipophilic anchors synthesized using methods, according to embodiments.
- FIG. 7 shows structures and ’H NMR spectra of six exemplary lipophilic anchors synthesized using methods, according to embodiments.
- FIG. 8 shows the confocal images of different cell membrane extracts coated on lipophilic anchor (3O-2S12), according to an embodiment, modified HMPs.
- FIG. 9 shows confocal images comparing sonication or vortexing at different treatment times to coat cell membrane vesicles on lipophilic anchor (3O-2S12), according to embodiments, modified HMPs.
- FIG. 10 shows confocal images of different lipids (DLPC, DSPC, POPG, POPC and cell membrane crude extracts) coated on hydrogel micro particles (HMPs) modified with a mono lipophobic anchor and exemplary lipophilic anchors, according to embodiments.
- FIG. 11 shows the confocal images over time after mixing lipophilic anchor decorated HMPs with POPC liposome.
- FIG. 12A shows confocal images of POPC coated HMPs with different lipophilic anchors varied in number of hydrophobic tails, and length of hydrophobic tails, according to embodiments.
- FIG. 12B shows confocal images of DSPC coated HMPs with different lipophilic anchors, according to embodiments, over time for HMPs after incubation in pH 7.4 PBS with 0.05 w/v% NaNs for about 37 °C.
- FIG. 13 shows the confocal images of different POPC liposome formulations comprising different Biotin-PE contents coated on lipophilic anchor (3O-2S12 and 40-3 S 12), according to embodiments, modified HMPs.
- FIG. 14 shows the confocal images of cell membrane vesicles coated lipophilic anchor (3O-2S12), according to embodiments, modified HMPs stored in cell culture medium at room temperature and 37 °C over 10 days.
- FIG. 15 shows the confocal images of POPC coated HMPs with different lipophilic anchors, according to embodiments, over time for HMPs incubated in MEM culture medium with 20% FBS and 0.05 w/v% NaNs, at about 37 °C .
- FIG. 16 shows the confocal images of POPC coated HMPs (hydrolysable) with different lipophilic anchors, according to embodiments, over time for HMPs incubated in respectively in RPMI-1640 culture medium with 10% FBS and 1% P/S, or in PBS, both at about 37 °C with 5% CO2 supply.
- the signal intensity is also quantified and plotted over time.
- a lipophilic anchor for adsorbing and stabilizing one or more target molecules having a lipophilic domain allows the deposition of the target molecules on a hydrophilic surface.
- the lipophilic anchors has a modular design of a conjugation domain coupled to an anchor domain by a linker domain.
- FIG. 2 shows nonlimiting exemplary reagents that can be used to synthesize the lipophilic anchors, according to embodiments.
- the conjugation domain serves to chemically conjugate the lipophilic anchor to a hydrophilic surface.
- the anchor domain assembles with a target molecule via hydrophobic interactions.
- the linker domain links the conjugation and anchor domains.
- One or more of: the conjugation domain; linker domain; and anchor domain is optionally cleavable from the bound anchor by hydrolysis, or enzymatic degradation, or other mechanism.
- the hydrophilic surface is on a hydrophilic substrate that readily wets with water, and can be a glass, metal, biological tissue, and hydrogel surface.
- the substrate may be flat or have curvature having any regular or irregular shape.
- the hydrophilic surface can be that of a hydrophilic spherical particle including a hydrogel, allowing formation of a cell mimic, an “artificial cell” with the attachment of a lipid layer or lipid bilayer membrane to the anchor domain of the lipophilic anchor. Such cell mimics may be used for immune cell therapy.
- the stable coating of the lipid shell on the hydrogel particles allows a fluidity of the cell mimic for interaction with a biological medium. Signaling proteins can be docked on the membrane allowing a mimic of the native interaction between natural cells.
- the hydrophilic surface has a multiplicity of reactive groups for bonding to one or more complementary functional groups on the lipophilic anchor, where the functional groups may be selected from, but are not limited to: acrylate; methacrylate; maleimide; vinylsulfone; aldehyde; acrylamide; vinyl; thiol; amine; derivatives thereof; and any combinations thereof.
- the conjugation domain comprises at least one functional group selected from, but not limited to: acrylate; methacrylate; maleimide; vinylsulfone; aldehyde; acrylamide; vinyl; thiol; amine; alkylamine: hydroxy; derivatives thereof, and any combination thereof.
- the linker domain is a structural unit that branches between one or more functional groups in the conjugation domain to a plurality of hydrophobic tails in the anchor domain.
- These two or more hydrophilic tails can be saturated, mono-unsaturated, or polyunsaturated hydrocarbons that can be linear, mono-branched, poly-branched, cyclic, polycyclic, or any combination thereof.
- the hydrophobic tails can be of 6 to 20 carbon atoms that can be uninterrupted or interrupted with one or two oxygen atom, sulfur atom, or a combination thereof.
- the hydrophobic tail can include a hydrocarbon that is 8 to 14 carbon atoms.
- the anchor domain can include two, three, four, or five hydrophobic tails to adsorb and stabilize target molecules with lipophilic domains via hydrophobic interactions.
- the substrate providing the hydrophilic surface is a hydrogel microparticle (HMP).
- the HMP can be a mixture of particles having a diameter of 0.1 to 10,000 micrometer, for example, the mixture can be 0.1 to 1 micrometer, 1-1000 micrometer, or 1-10 millimeter, with a narrow or broad distribution of diameters.
- the HMP can be a polymeric gel formed from one or mor polymer precursors having a weight averaged molecular weight of about 5 kDa to about 3000 kDa.
- a polymer can be a homopolymer, copolymer, or terpolymer, where the co- or terpolymer can be random, block, linear, branched, or hyperbranched.
- the precursor can have complementary functional groups for attachment to their compliment in the conjugation domain where the precursor has, for example, but not limited to, about 1% to 30% of the polymers repeating units.
- the complementary functional groups can be randomly or non-randomly dispersed and can be homogeneously situated within the HMP or concentrated on or near the external surface of the HMP.
- the HMPs forming precursors consist hydrophilic monomers with reactive functional groups selected from acrylate, methacrylate, maleimide, vinylsulfone, aldehyde, acrylamide, vinyl, thiol, amine, alkyl amine, hydroxy, derivative thereof, and any combinations thereof.
- the HMPs can be formed prior to modification with the lipid anchor or the HMPs can be formed and simultaneously modified with the lipid anchor.
- the lipophilic anchors on a hydrophilic surface increases the amount of adsorbed target molecules from an aqueous environment.
- the amount of target molecules being adsorbed on a hydrophilic surface in an aqueous environment is varied by varying the modification density of lipophilic anchors.
- the modification density of lipophilic anchors on a hydrophilic surface is adjustable by changing the amount of complementary reactive functional groups on the hydrophilic surface, or inside the substance providing the hydrophilic surface.
- the efficiency of adsorbing specific target molecules or desired combinations of target molecules from the aqueous environment on the hydrophilic surface is adjustable.
- the target molecules of the lipophilic domains are selected from phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylglycerols (PG), phosphatidylserines (PS), sterols, dye molecules, fluorescent dye molecules, saccharolipids, lipopeptides, lipoproteins, and crude membrane components extracted from mammalian cells.
- PC phosphatidylcholines
- PE phosphatidylethanolamines
- PG phosphatidylglycerols
- PS phosphatidylserines
- sterols dye molecules, fluorescent dye molecules, saccharolipids, lipopeptides, lipoproteins, and crude membrane components extracted from mammalian cells.
- FIG. 3 The inclusion of the lipophilic anchors on the hydrophilic surface prolongs the adhesion time of target molecules being adsorbed depending upon the structure and quantity of the lipophilic anchors.
- the adhesion time can range from 1
- the aqueous environment can be a physiological or mammalian cells cocultures.
- the adhesion time can be based on the degradation rate of cleavable groups embedded within the lipophilic anchors or cleavable groups between the hydrophilic surface and the lipophilic anchors.
- the cell mimics can be used to modulate functions of other immune cells, for example production of CAR-T cells, or as a biomaterial platform for vaccine applications.
- the lipophilic anchor domain stabilized lipid coated particles can be used as a platform for high throughput lipopeptide/lipoprotein signal screening.
- the lipid surface stabilized by the lipid anchor on a hydrophilic surface can be employed can be employed to establish a lipophilic anchor library for the systematically analyze of or screen for the effects of different anchor structures and the resulting membrane stability in a physiological environment, especially in cell culture media with proteins.
- the lipophobic anchors can allow the coating of liposomes formulated by synthetic lipids or by cell membrane extracts.
- Standard abbreviations used include: bp, base pair(s); kb, kilobase(s); pl, picoliter(s); s, sec, or second(s); min or minute(s); h, hr, or hour(s); aa, amino acid(s); nt, nucleotide(s); i.m., intramuscular(ly); i.p., intraperitoneal(ly); s.c., subcutaneous(ly); and the like.
- HMPs hydrogel microparticles
- hydrogel forming precursors were prepared using methods disclosed in Lau, Chi Ming Laurence, et al. "Controllable multi -phase protein release from in-situ hydrolysable hydrogel.” Journal of Controlled Release 335 (2021): 75-85.
- Dextran-based hydrogel microparticles (HMPs) were prepared using the microfluidic flow focusing methods disclosed in Chung, Casper HY, et al. "Droplet-Based Microfluidic Synthesis of Hydrogel Microparticles via Click Chemistry-Based Cross-Linking for the Controlled Release of Proteins.” ACS Applied Biomaterials 4.8 (2021): 6186-6194, or using porous membrane aided batch emulsion.
- Microfluidic flow focusing method Hydrogel forming precursors were dissolved in a buffer with pH ranged from 5-6, or 6-7, or 7-8, and subsequently mixed and injected to n- heptane or mineral oil as the continuous phase, using 1-4 % v/v SPAN80, a mixture of SPAN80/TWEEN80, or EM90 as the surfactants. Droplets were incubated at room temperature for at least one hour to allow gelation. Amounts of unreacted thiol groups remaining in the HMPs, were confirmed by adding HMPs into Ellman’s reagent.
- Porous membrane aided batch emulsion method Hydrogel-forming precursors and oil phase were prepared in the same way as described in the microfluidic flow focusing method.
- the materials to be encapsulated such as recombinant proteins, nucleic acids, nanoparticles, or microparticles, are added to one or both precursor solutions to create a mixture of solution or suspension.
- the hydrogel-forming precursors Prior to mixing, the hydrogel-forming precursors are kept in an ice bath. After thorough mixing, the aqueous phase mixture is transferred to the oil phase. The volume of the aqueous phase is less than 30% v/v of the oil phase.
- the aqueous droplets are formed by passing the aqueous phase mixture and the oil phase through a porous membrane multiple time (2-30 times).
- HMPs contain a certain amount of unreacted thiol groups, which can be confirmed by a positive result from adding HMPs to Ellman’s reagent.
- Exemplary lipophilic anchors synthesized by reacting a series of thiolated hydrocarbons with varied length (8-16 carbons) with various multi -acrylate core molecules are illustrated in FIG. 4.
- the exemplary multi -acrylate core molecules trimethylolpropane triacrylate (30); pentaerythritol tetraacrylate (40); or dipentaerythritol hexaacrylate (60) were dissolved in dimethylformamide (DMF) to a concentration of about 0.05-0.2 M, and added with thiolated hydrocarbons (e.g 1 -octanethiol (S8), 1 -decanethiol (S10), 1- dodecanethiol(S12), 1 -tetradecanethiol (SI 4), l-hexadecanethiol(S16)) at an equivalent feeding ratio to react using a desired number, for example, 2, 3, 4, or 5 thiolated hydrocarbons with the acrylates of the
- a typical reaction was conducted at a temperature of about 15-50 °C for about 4-24 hours. If lipophilic anchors precipitate during the reaction, for example, 3O-2S16, 4O-3S12, 4O-3S14, 4O-3S16, 6O-4S12, 6O-5S12, 2-6 mL of chloroform was added to the reaction mixture to dissolve the precipitations. The reaction endpoint was determined by detecting minimum residual amount of free thiol groups in the reaction mixture using Ellman’s reagent. The lipophilic anchors were extracted using chloroform: methanol (3: 1-2: 1) and washed 3-10 times with dilute HC1 (0.01-0.05M) and water. Residual chloroform was removed by purging with nitrogen gas and vacuum drying to yield crude products as a viscous liquid or a waxy solid.
- an optional functional group donor e.g DL-dithiothreitol (DTT)
- DTT DL-dithiothreitol
- HLB hydrophilic-lipophilic balance
- Lipophilic Core lipid tail anchor lipid tail anchor molecule No. TEA (pL) DMF(mL) lipid tails vol (pL) code No. mmol mmol 3O-2S8 0.241 2 0.482 86 67 4 ⁇ 8 3O-2S10 0.281 2 0.561 123 78 5.6 3O-2S12 0.278 2 0.555 140 77 5.6 3O-2S14 0.276 2 0.552 154 77 5.5 3O-2S16 0.348 2 0.697 218 97 7.0 40-3 S8 0.287 3 0.860 153 120 5.7 40-3 S 10 0.324 3 0.971 212 135 6.5 4O-3S12 0.285 3 0.854 215 119 5.7 4O-3S14 0.292 3 0.875 245 122 5.8 40-3 S 16 0.299 3 0.897 281 125 6.0 4O-2S12 0.92 2 1.84 465 258 9.2 6O-4S12 0.39 4 1.17 298 328 7.8
- preformed HMPs containing free vinyl sulfone, acrylate, methacrylate, maleimide, or thiol groups were washed three times with excess n-heptane or DMF and transferred to a lipophilic anchor solution using a nonpolar organic solvent such as n-heptane or a polar organic solvent such as DMF.
- a nonpolar organic solvent such as n-heptane or a polar organic solvent such as DMF.
- a lipophilic anchor solution was prepared by dissolving anchors in n- heptane, or DMF to a concentration of about 1-8 v/v%. The mixture was homogenized by pipetting and vortex. For anchors having lipophilic anchors that do not dissolve in DMF under ambient temperature, a controlled amount of DCM, or chloroform was added to solubilize the anchors. Triethylamine (TEA) was added at 0.05-0.2M to catalyze the reaction. The HMP-anchor mixture was incubated for 2-36 hours with shaking at ambient temperature in a sealed glass container to allow conjugation of lipophilic anchors on the HMPs surface. Unconjugated lipophilic anchors were sequentially washed with excess DMF and ethanol multiple times. Anchor modified HMPs were preserved in ethanol.
- TAA Triethylamine
- Synthetic or natural product extracted phospholipids including 12:0 PC (DLPC), 16:0- 18: 1 PC (POPC), 18:0 PC (DSPC), 16:0-18: 1 PG (POPG), 18: 1 Liss Rhod PE (LissRhoPE), 18: 1 Biotinyl Cap PE (biotinPE) were coated on lipophilic anchor modified surface of HMPs. LissRhoPE was added at 0.1% to all liposome formulations as a color indicator.
- Liposomes comprising DLPCLissRhoPE 99.9:0.1; POPCLissRhoPE 99.9:0.1 were prepared using ethanol injection method.
- DLPC and LissRhoPE were dissolved in ethanol separately, then mixed at molar ratio of 99.9:0.1.
- the mixture was rapidly injected to PBS of at least 10 times larger volume to a final lipid concentration of 1-2 mM, vortex mixed, then vacuum dried to remove the ethanol.
- POPCLissRhoPE liposome was prepared using the same method.
- Liposomes comprising DSPCLissRhoPE 99.9:0.1; POPG:LissRhoPE 99.9:0.1 were prepared using film hydration method. Separately, DLPC or POPG and LissRhoPE were dissolved in chloroform and ethanol, respectively. Then mixed at molar ratio of 99.9:0.1. Chloroform and ethanol were evaporated in a vacuum with heating to about 60°C to form a viscous thin film. The film was rehydrated with pre-warmed PBS to have a final concentration of 1-2 mM and vortex mixed to form liposomes.
- liposomes suspension was mixed with HMPs, homogenized by vortex mixing, then incubated at ambient temperature for 1-48 hours. In some cases, brief sonication and repeated freeze-thaw cycles were applied to facilitate lipid coating. Afterwards, uncoated liposomes were washed with excess PBS, and stored in pH 7.4 PBS at 4°C.
- Vortexing and sonication were evaluated to coat 4O-3S12 HMPs with cell membrane vesicles. Both vortexing and sonication facilitate the adsorption of cell membrane vesicles on the 40-3 S 12 HMPs, as indicated in FIG. 9, however, sonication for more than 5 minutes resulted in aggregation of vesicles affecting consistency of the coating. Membrane coating content can be increased by increasing the vortexing time, although aggregation of HMPs appears to occur at longer time intervals.
- the amount of synthetic lipids (e.g DLPC, DSPC, POPG, POPC), and mammalian cell membrane contents (e.g HeLa, RAW264.7 and JAWS II) adsorbed onto the HMPs surface was estimated based on the fluorescent signals of LissRhoPE at 561/594 nm using confocal microscopy images, as illustrated in FIG. 10, employing common imaging settings for all examples.
- synthetic lipids e.g DLPC, DSPC, POPG, POPC
- mammalian cell membrane contents e.g HeLa, RAW264.7 and JAWS II
- the lipophilic anchor 40-3 S 12 exhibited a universal high capability to adsorb different types of synthetic lipids being tested, such as DLPC, DSPC, POPG, POPC.
- Anchor 3O-2S12 had comparable performance to adsorb POPC, but less effective for DLPC, DSPC and POPG adsorption. Further increasing the number of hydrophobic tails attenuated the lipid adsorption capability. Lipophilic anchors having 2 and 3 hydrophobic tails in the anchor domain demonstrated the highest lipid adsorption, with 3 hydrophobic tails demonstrating a higher versatility for different types of lipids.
- Exemplary lipophilic anchors with single or triple hydrophobic tails of varying lengths from 8 to 16 carbons along the backbone showed different abilities to absorb POPC or DSPC liposomes containing 0.1% Rhodamine PE, as indicated by the amount of lipids coated.
- Anchors with 8 to 10 carbon tails exhibited the highest lipid absorption for single-tail anchors, as shown in FIG 12 A. Increased tail length was found to decrease the amount of lipids absorbed.
- tail lengths from 8 to 14 carbons yielded comparable lipid absorption, but increasing the tail length to 16 carbons reduced the lipid coating capability.
- Liposomes with different lipid compositions having varied fractions of different types of lipids were coated on the HMPs modified with 3O-2S12 and 4O-3S12 according to the following table:
- the HMPs were incubated with 0.1 mg/mL neutravidin, or avidin with/without FITC to graft biotin docking sites onto the HMP surface. Reaction was conducted in 1% BSA/PBS for 60 mins at ambient temperature to avoid unspecific bindings. Unbound avidin was thoroughly washed with PBS.
- Fite labeled avidin was used to quantify the amount of avidin grafted on different HMP formulations differed in biotin contents. Fitc-avidin was expected to bind the exposed biotin group on the HMPs surface, and the amount of Fitc-avidin was expected to correlate with the biotin PE fraction of the liposome formulation coated.
- lipid coated HMPs were incubated in PBS (pH7.4) with 0.05 w/v% NaNs, about 37 °C as shown in Fig. 12B.
- lipid coated HMPs were incubated in Minimum Essential Medium (MEM) with 20% FBS and 0.05 w/v% NaNs, at about 37 °C, as shown in Fig. 15.
- MEM Minimum Essential Medium
- lipid coated HMPs were incubated in RPMI media with 10% FBS, 1% penicillin-streptomycin, and PBS at about 37 °C respectively with 5% CO2, as shown in Fig 16.
- Embodiment 1 A lipophilic anchor, comprising a conjugation domain linked via a linker domain to a an anchor domain comprising a plurality of hydrophobic tails, whereby at least one lipophilic target molecule with affinity to the anchor domain can be deposited on a hydrophilic surface conjugated to the conjugation domain.
- Embodiment 2 The lipophilic anchor according to embodiment 1, wherein the conjugation domain is derived upon reaction of at least one first molecule comprising at least one functional group selected from: acrylate, methacrylate, maleimide, vinylsulfone, aldehyde, acrylamide, vinyl, thiol, amine, alkylamine, hydroxy, derivatives of any of the foregoing, and any combination thereof.
- Embodiment 3 The lipophilic anchor according to embodiment 2, wherein the at least one functional group is an acrylate or a thiol.
- Embodiment 4 The lipophilic anchor according to embodiment 1, wherein the hydrophobic tails comprises at least one saturated, mono-unsaturated, or polyunsaturated hydrocarbon, where the hydrocarbon is linear, mono-branched, poly-branched, cyclic, polycyclic, or any combination thereof.
- Embodiment 5 The lipophilic anchor according to embodiment 4, wherein the hydrocarbon comprises 6 to 20 carbon atoms optionally interrupted with one or two oxygen atoms, sulfur atoms, or a combination thereof.
- Embodiment 6 The lipophilic anchor according to claim 4, wherein the hydrocarbon comprises 8 to 14 carbon atoms optionally interrupted with one or two oxygen atoms, sulfur atoms, or a combination thereof.
- Embodiment 7 The lipophilic anchor according to embodiment 1, wherein the anchor domain is derived from a second molecule comprising 2 to 6 hydrophobic tails.
- Embodiment 8 The lipophilic anchor according to embodiment 6, wherein the second molecule comprises 2 or 3 hydrophobic tails.
- Embodiment 9 The lipophilic anchor according to embodiment 1, wherein the linker domain is a structural unit generated upon reaction of the first molecule to the second molecule.
- Embodiment 10 A lipophilic target molecule coated hydrophilic substrate, comprising: a multiplicity of reaction residues of the functionality of the lipophilic anchor according to embodiment 1 and a complimentary functionality to the functionality of the conjugation domain of the lipophobic anchor on at least a hydrophilic surface of the hydrophilic substrate; and a multiplicity of lipophilic target molecules non-covalently bound to the plurality of hydrophobic tails of the anchor domain.
- Embodiment 11 The lipophilic target molecule coated hydrophilic substrate according to embodiment 9, wherein the hydrophilic surface comprises a hydrophilic polymer.
- Embodiment 12 The lipophilic target molecule coated hydrophilic substrate according to embodiment 9, wherein the hydrophilic substrate comprises a hydrogel.
- Embodiment 13 The lipophilic target molecule coated hydrophilic substrate according to embodiment 11, wherein the hydrogel is a dextran-based hydrogel.
- Embodiment 14 The lipophilic target molecule coated hydrophilic substrate according to embodiment 10, wherein the multiplicity of lipophilic target molecules are selected from at least one biomolecule.
- Embodiment 15 The lipophilic target molecule coated hydrophilic substrate according to embodiment 14, wherein the at least one biomolecule is selected from phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylglycerols (PG), phosphatidylserines (PS), sterols, saccharolipids, lipopeptides, lipoproteins, and crude membrane components extracted from mammalian cells.
- PC phosphatidylcholines
- PE phosphatidylethanolamines
- PG phosphatidylglycerols
- PS phosphatidylserines
- sterols saccharolipids, lipopeptides, lipoproteins, and crude membrane components extracted from mammalian cells.
- Embodiment 16 The lipophilic target molecule coated hydrophilic substrate according to embodiment 10, wherein the lipophilic target molecule is a lipid bilayer and the lipophilic target molecule coated hydrophilic substrate is a cell mimic.
- Embodiment 17 A method of preparing the lipophilic anchor according to embodiment 1, comprising: providing a first molecule comprising a multiplicity of functional groups selected from: acrylate, methacrylate, maleimide, vinylsulfone, aldehyde, acrylamide, vinyl, thiol, amine, alkylamine, hydroxy, derivatives of any of the foregoing, and any combination thereof; providing a second molecule comprising at least one hydrophobic tail selected from saturated, mono-unsaturated, and polyunsaturated hydrocarbons and a multiplicity of complimentary functional groups; combining the first molecule and the second molecule and optionally a solvent and/or a catalyst or an initiator; and isolating the lipophilic anchor comprising the conjugation domain from the first molecule, the anchor domain from the second molecule and the linker domain resulting from a reaction between the functional groups and the complimentary functional groups.
- Embodiment 18 The method according to embodiment 17, wherein the functionality is an acrylate, and the complementary functionality is
- Embodiment 19 The method according to embodiment 17, wherein the optional catalyst is a trialkyl amine.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/565,591 US20250102498A1 (en) | 2022-07-17 | 2023-07-13 | Compositions of lipophilic anchors and the use thereof |
| CN202380012142.7A CN117916222A (en) | 2022-07-17 | 2023-07-13 | Composition of lipophilic anchor and its application |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263389897P | 2022-07-17 | 2022-07-17 | |
| US63/389,897 | 2022-07-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2024018286A2 true WO2024018286A2 (en) | 2024-01-25 |
| WO2024018286A3 WO2024018286A3 (en) | 2024-04-25 |
Family
ID=89617258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2023/000557 Ceased WO2024018286A2 (en) | 2022-07-17 | 2023-07-13 | Compositions of lipophilic anchors and the use thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20250102498A1 (en) |
| CN (1) | CN117916222A (en) |
| WO (1) | WO2024018286A2 (en) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058006A1 (en) * | 1997-10-14 | 2004-03-25 | Alnis Biosciences, Inc. | High affinity nanoparticles |
| AUPQ234599A0 (en) * | 1999-08-20 | 1999-09-16 | Lamb, Robert Norman | Hydrophobic material |
| US20080267876A1 (en) * | 2005-09-20 | 2008-10-30 | Yissum Research Development Company | Nanoparticles for Targeted Delivery of Active Agent |
| US20090246249A1 (en) * | 2008-03-27 | 2009-10-01 | Affinergy | Coating compositions having improved performance |
| JP6144466B2 (en) * | 2012-06-29 | 2017-06-07 | ポーラ化成工業株式会社 | Topical skin preparation |
| CA2929970C (en) * | 2013-12-20 | 2020-05-12 | F. Hoffmann-La Roche Ag | Method of immobilizing a cell on a support using compounds comprising a polyethylene glycol moiety |
| ES2688518T3 (en) * | 2014-06-03 | 2018-11-05 | Karlsruher Institut für Technologie | Superhydrophobic reactive surfaces, superhydrophobic patterned surfaces, methods for producing them and use of superhydrophobic patterned surfaces |
| WO2020104302A1 (en) * | 2018-11-20 | 2020-05-28 | Agfa-Gevaert Nv | Radiation curable inkjet ink for manufacturing printed circuit boards |
| CN113698654B (en) * | 2020-05-22 | 2022-09-27 | 华中科技大学 | Hydrogel with hydrophobic surface, and preparation and application thereof |
-
2023
- 2023-07-13 US US18/565,591 patent/US20250102498A1/en active Pending
- 2023-07-13 CN CN202380012142.7A patent/CN117916222A/en active Pending
- 2023-07-13 WO PCT/IB2023/000557 patent/WO2024018286A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20250102498A1 (en) | 2025-03-27 |
| CN117916222A (en) | 2024-04-19 |
| WO2024018286A3 (en) | 2024-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Biphasic biocatalysis using a CO 2-switchable Pickering emulsion | |
| Afshari et al. | Materials functionalization with multicomponent reactions: state of the art | |
| Zhou et al. | Preparation of protein imprinted polymer beads by Pickering emulsion polymerization | |
| Scott et al. | Pickering stabilized peptide gel particles as tunable microenvironments for biocatalysis | |
| Ruysschaert et al. | Liposome-based nanocapsules | |
| CN109320739B (en) | A light- and pH-responsive amphiphilic alginate and its stable pickering emulsion | |
| Rocha-Garcia et al. | Gelatin-based porous silicon hydrogel composites for the controlled release of tramadol | |
| Du et al. | Preparation of highly cross-linked raspberry-like nano/microspheres and surface tailoring for controlled immunostimulating peptide adsorption | |
| CN112813104A (en) | Preparation method and application of protein-polymer composite nano material gene vector | |
| Timin et al. | Application of guanidine-containing polymers for preparation of pH responsive silica-based particles for drug delivery systems | |
| WO2015133439A1 (en) | Pullulan gel, method for producing same, and use of same | |
| EP0777691A1 (en) | Novel calibrated monodisperse magnetisable microsphere latex, preparation method therefor and use thereof in chemistry or biology | |
| US20250102498A1 (en) | Compositions of lipophilic anchors and the use thereof | |
| EP1325334B1 (en) | Method for immobilising lipid layers | |
| CN116179530B (en) | A chitosan emulsifying material with an immobilized enzyme and its application in the catalytic esterification reaction to synthesize phytosterol acetate. | |
| KR20170109207A (en) | Fibroblast growth factor-heparin complexes conjugated by chemical reaction and preparation method thereof | |
| Nehring et al. | Protein decorated membranes by specific molecular interactions | |
| CN115216034B (en) | Silk protein/lysozyme transferable protein nano film or coating and preparation thereof | |
| Belegrinou et al. | Solid-supported polymeric membranes | |
| Wang et al. | In situ fabrication of PHEMA–BSA core–corona biohybrid particles | |
| HK40103420A (en) | Compositions of lipophilic anchors and the use thereof | |
| Chibowski et al. | Surface modification of glass plates and silica particles by phospholipid adsorption | |
| Ahmad et al. | Preparation of micron-sized composite polymer particles containing hydrophilic 2-hydroxyethyl methacrylate and their biomedical applications | |
| JPH01294701A (en) | Oligosaccharide ester of fatty acid | |
| CN104447949B (en) | Polypeptide and pharmaceutical composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 18565591 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202380012142.7 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23842507 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWP | Wipo information: published in national office |
Ref document number: 18565591 Country of ref document: US |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 23842507 Country of ref document: EP Kind code of ref document: A2 |